OTC Pain

Press enter to search
Close search
Open Menu

OTC Pain

News and information on OTC pain products, merchandising and trends in retail pharmacies.

Children’s Tylenol Dissolve Packs

Tylenol launches Children’s Tylenol Dissolve Packs

Johnson & Johnson Consumer is introducing the first new form of Children’s Tylenol in 10 years.

Rob Gronkowski, Abacus Health Products partner on line

Abacus Health Products, maker of CBDMedic, is partnering with NFL star Rob Gronkowski on a line of recovery solutions launching in 2020.

Marina Karp has been named to the newly created role, tasked with helping develop CHPA’s health policy priorities and engage stakeholders regarding the value of OTCs, dietary supplements and consumer medical devices, the organization said.

Pfizer and GlaxoSmithKline have closed their joint venture to combine their respective consumer healthcare businesses and form the world’s largest over-the-counter business. This new venture will operate as the new GSK Consumer Healthcare.

The company named John Salley its executive vice president of marketing, effective immediately, and tasked him with helping market Leading Edge Pharms’ Cananvera line of CBD-based topical pain and inflammation products.

New data from the Consumer Healthcare Products Association and IRI is highlighting the ripple effect that a consumer buying an OTC product can have on the American healthcare system — namely, some $146 billion in savings.

The Taro Pharmaceuticals brand has expanded its distribution nationwide to Target stores and Target.com.

CVS Pharmacy confirmed it would be selling CBD products in select stores in such states as California, Colorado, Illinois, Indiana, Kentucky, Maryland and Tennessee.

Instaflex’s Pain Relief Cream works to relieve pain from such conditions as arthritis, back pain, strains, joint and muscle pain, the company said.

The House of Representatives on Tuesday passed H.R. 269 — a package of bills that legislation aimed at modernizing the OTC monograph process — gaining praise from industry organizations.

GlaxoSmithKline will have a controlling 68% equity interest and Pfizer will have a 32% equity interest in the joint venture, which would have a global OTC market share of 7.3%, leading the market in most key geographical areas, including the United States and China.

The company purchased the North American distribution rights for PanOxyl, Sarna, Zeasorb, Desenex and Mineral Ice from GlaxoSmithKline.

Procter & Gamble has completed its €3.2 billion acquisition of Darmstadt, Germany-based Merck KGaA’s consumer health business.

Quest Products has introduced the ProVent Hemp Patch for pain relief and ProVent Wart Remover with natural botanicals.

Show More